Protein testing for muscle loss in chronic lung disease
Part of Brain & nervous system clinical trials.
This study looks at proteins in the blood to understand muscle loss (sarcopenia) in people with chronic lung disease. It aims to find better ways to detect and manage this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have been diagnosed with a chronic lung disease
- You are willing to provide a blood sample and participate in the study
- You do not have other serious health conditions like heart failure, advanced liver or kidney disease, uncontrolled diabetes, or cancer
- You have not had a recent flare-up of your lung disease or another acute illness
- You have not had surgery in the last 6 months or taken long-term steroids, chemotherapy, or radiation
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new clinic designed to help people with COPD who have lost muscle mass (sarcopenia). By using a CT scan done during your hospital stay, doctors can identify muscle loss and offer treatments to help you regain strength and function.
This study looks at muscle loss (sarcopenia) in people with lung cancer who are about to have surgery. It uses a CT or MRI scan to check your muscle health, which may help doctors better plan your care.
This study looks at muscle loss (sarcopenia) in people with multiple sclerosis. It aims to understand what factors are linked to muscle loss, which could help improve care.
This trial studies whether adding a dietary supplement to exercise can improve muscle strength in people with muscle loss (sarcopenia) who also have lung disease such as COPD or ILD. It may help you build strength and function without needing urgent hospital care.
This trial tests a new approach to treat sarcopenia (age-related muscle loss) by targeting a protein called HIF-1α. It compares older adults with sarcopenia to younger adults without it, all of whom are having hip or knee surgery.
This study looks at how loss of muscle strength or mass (sarcopenia) relates to advanced liver disease. It may help doctors understand which patients are at higher risk and could guide future care choices.
Hear when a new Sarcopenia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.